Molecular and cellular aspects of rhabdovirus entry

Viruses

Volumn 4, Issue 1, 2012, Pages 117-139

  Albertini, Aurélie A V ^a   Baquero, Eduard ^a   Ferlin, Anna ^a   Gaudin, Yves ^a  

^a INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

Author keywords

Endocytosis; Glycoprotein; Membrane fusion; Rabies virus; Rhabdovirus; Vesicular stomatitis virus

Indexed keywords

NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR RECEPTOR; NICOTINIC RECEPTOR; VIRUS GLYCOPROTEIN;

CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; MEMBRANE FUSION; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN REFOLDING; REVIEW; RHABDOVIRUS; STRUCTURE ANALYSIS; VESICULAR STOMATITIS VIRUS; VIRUS ATTACHMENT; VIRUS ENTRY;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; ENDOCYTOSIS; ENDOSOMES; GENOME, VIRAL; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MICE; NEURONS; PROTEIN CONFORMATION; RECEPTORS, VIRUS; RHABDOVIRIDAE; RHABDOVIRIDAE INFECTIONS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS INTERNALIZATION;

RABIES VIRUS; RHABDOVIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 84856278976     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v4010117     Document Type: Review

References (119)

1. Rose, J.K.; Whitt, M.A. Rhabdoviridae: The viruses and their replication. In Fields Virology, 4th ed.; Lippincott-Raven Publishers, Philadelphia, PA, USA, 2001; pp. 1221-1224.
2. Fort, P.; Albertini, A.; Van-Hua, A.; Berthomieu, A.; Roche, S.; Delsuc, F.; Pasteur, N.; Capy, P.; Gaudin, Y.; Weill, M. Fossil rhabdoviral sequences integrated into arthropod genomes: Ontogeny, evolution, and potential functionality. Mol. Biol. Evol. 2011, doi:10.1093/molbev/msr226.
3. Mebatsion, T.; Weiland, F.; Conzelmann, K.K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 1999, 73, 242-250.
4. Doms, R.W.; Keller, D.S.; Helenius, A.; Balch, W.E. Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers. J. Cell Biol. 1987, 105, 1957-1969.
5. Gaudin, Y.; Ruigrok, R.W.; Tuffereau, C.; Knossow, M.; Flamand, A. Rabies virus glycoprotein is a trimer. Virology 1992, 187, 627-632.
6. Whitt, M.A.; Buonocore, L.; Prehaud, C.; Rose, J.K. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology 1991, 185, 681-688.
7. Balch, W.E.; Elliott, M.M.; Keller, D.S. ATP-coupled transport of vesicular stomatitis virus G protein between the endoplasmic reticulum and the Golgi. J. Biol. Chem. 1986, 261, 14681-14689.
8. Kreis, T.E.; Lodish, H.F. Oligomerization is essential for transport of vesicular stomatitis viral glycoprotein to the cell surface. Cell 1986, 46, 929-937.
9. Lyles, D.S.; Varela, V.A.; Parce, J.W. Dynamic nature of the quaternary structure of the vesicular stomatitis virus envelope glycoprotein. Biochemistry 1990, 29, 2442-2449.
10. Wilcox, M.D.; McKenzie, M.O.; Parce, J.W.; Lyles, D.S. Subunit interactions of vesicular stomatitis virus envelope glycoprotein influenced by detergent micelles and lipid bilayers. Biochemistry 1992, 31, 10458-10464.
11. Zagouras, P.; Ruusala, A.; Rose, J.K. Dissociation and reassociation of oligomeric viral glycoprotein subunits in the endoplasmic reticulum. J. Virol. 1991, 65, 1976-1984.
12. Gaudin, Y. Folding of rabies virus glycoprotein: Epitope acquisition and interaction with endoplasmic reticulum chaperones. J. Virol. 1997, 71, 3742-3750.
13. Hammond, C.; Helenius, A. Folding of VSV G protein: Sequential interaction with BiP and calnexin. Science 1994, 266, 456-458.
14. Mathieu, M.E.; Grigera, P.R.; Helenius, A.; Wagner, R.R. Folding, unfolding, and refolding of the vesicular stomatitis virus glycoprotein. Biochemistry 1996, 35, 4084-4093.
15. Flamand, A.; Raux, H.; Gaudin, Y.; Ruigrok, R.W. Mechanisms of rabies virus neutralization. Virology 1993, 194, 302-313.
16. Lefrancois, L.; Lyles, D.S. Antigenic determinants of vesicular stomatitis virus: analysis with antigenic variants. J. Immunol. 1983, 130, 394-398.
17. Prehaud, C.; Coulon, P.; LaFay, F.; Thiers, C.; Flamand, A. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J. Virol. 1988, 62, 1-7.
18. Seif, I.; Coulon, P.; Rollin, P.E.; Flamand, A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 1985, 53, 926-934.
19. Vandepol, S.B.; Lefrancois, L.; Holland, J.J. Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus. Virology 1986, 148, 312-325.
20. Coulon, P.; Ternaux, J.P.; Flamand, A.; Tuffereau, C. An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro. J. Virol. 1998, 72, 273-278.
21. Tuffereau, C.; Leblois, H.; Benejean, J.; Coulon, P.; Lafay, F.; Flamand, A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989, 172, 206-212.
22. Benmansour, A.; Leblois, H.; Coulon, P.; Tuffereau, C.; Gaudin, Y.; Flamand, A.; Lafay, F. Antigenicity of rabies virus glycoprotein. J. Virol. 1991, 65, 4198-4203.
23. Lafay, F.; Benmansour, A.; Chebli, K.; Flamand, A. Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites. J. Gen. Virol. 1996, 77, 339-346.
24. Raux, H.; Coulon, P.; Lafay, F.; Flamand, A. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing. Virology 1995, 210, 400-408.
25. Dietzschold, B.; Gore, M.; Marchadier, D.; Niu, H.S.; Bunschoten, H.M.; Otvos, L., Jr.; Wunner, W.H.; Ertl, H.C.; Osterhaus, A.D.; Koprowski, H. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J. Virol. 1990, 64, 3804-3809.
26. Lafon, M.; Wiktor, T.J.; Macfarlan, R.I. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J. Gen. Virol. 1983, 64, 843-851.
27. Schlegel, R.; Tralka, T.S.; Willingham, M.C.; Pastan, I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983, 32, 639-646.
28. Coil, D.A.; Miller, A.D. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J. Virol. 2004, 78, 10920-10926.
29. Sinibaldi, L.; Goldoni, P.; Seganti, L.; Superti, F.; Tsiang, H.; Orsi, N. Gangliosides in early interactions between vesicular stomatitis virus and CER cells. Microbiologica 1985, 8, 355-365.
30. Bloor, S.; Maelfait, J.; Krumbach, R.; Beyaert, R.; Randow, F. Endoplasmic reticulum chaperone gp96 is essential for infection with vesicular stomatitis virus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 6970-6975.
31. Kissling, R.E. Growth of rabies virus in non-nervous tissue culture. Proc. Soc. Exp. Biol. Med. 1958, 98, 223-225.
32. Wiktor, T.J.; Fernandes, M.V.; Koprowski, H. Cultivation Of rabies virus in human diploid cell strain Wi-38. J. Immunol. 1964, 93, 353-366.
33. Schneider, L.G.; Horzinek, M.; Matheka, H.D. Purification of rabies virus from tissue culture. Arch. Gesamte Virusforsch. 1971, 34, 351-359.
34. Seganti, L.; Superti, F.; Bianchi, S.; Orsi, N.; Divizia, M.; Pana, A. Susceptibility of mammalian, avian, fish, and mosquito cell lines to rabies virus infection. Acta Virol. 1990, 34, 155-163.
35. Lafon, M. Rabies virus receptors. J. Neurovirol. 2005, 11, 82-87.
36. Superti, F.; Seganti, L.; Tsiang, H.; Orsi, N. Role of phospholipids in rhabdovirus attachment to CER cells. Brief report. Arch. Virol. 1984, 81, 321-328.
37. Conti, C.; Superti, F.; Tsiang, H. Membrane carbohydrate requirement for rabies virus binding to chicken embryo related cells. Intervirology 1986, 26, 164-168.
38. Superti, F.; Hauttecoeur, B.; Morelec, M.J.; Goldoni, P.; Bizzini, B.; Tsiang, H. Involvement of gangliosides in rabies virus infection. J. Gen. Virol. 1986, 67, 47-56.
39. Lentz, T.L.; Burrage, T.G.; Smith, A.L.; Crick, J.; Tignor, G.H. Is the acetylcholine receptor a rabies virus receptor? Science 1982, 215, 182-184.
40. Lentz, T.L.; Wilson, P.T.; Hawrot, E.; Speicher, D.W. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science 1984, 226, 847-848.
41. Lentz, T.L.; Benson, R.J.; Klimowicz, D.; Wilson, P.T.; Hawrot, E. Binding of rabies virus to purified Torpedo acetylcholine receptor. Brain Res. 1986, 387, 211-219.
42. Gastka, M.; Horvath, J.; Lentz, T.L. Rabies virus binding to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay. J. Gen. Virol. 1996, 77, 2437-2440.
43. McGehee, D.S.; Role, L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 1995, 57, 521-546.
44. Burrage, T.G.; Tignor, G.H.; Smith, A.L. Rabies virus binding at neuromuscular junctions. Virus Res. 1985, 2, 273-289.
45. Thoulouze, M.I.; Lafage, M.; Schachner, M.; Hartmann, U.; Cremer, H.; Lafon, M. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 1998, 72, 7181-7190.
46. Tuffereau, C.; Benejean, J.; Blondel, D.; Kieffer, B.; Flamand, A. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 1998, 17, 7250-7259.
47. Langevin, C.; Tuffereau, C. Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein. J. Virol. 2002, 76, 10756-10765.
48. Tuffereau, C.; Desmezieres, E.; Benejean, J.; Jallet, C.; Flamand, A.; Tordo, N.; Perrin, P. Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR. J. Gen. Virol. 2001, 82, 2861-2867.
49. Tuffereau, C.; Schmidt, K.; Langevin, C.; Lafay, F.; Dechant, G.; Koltzenburg, M. The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J. Virol. 2007, 81, 13622-13630.
50. Bearzotti, M.; Delmas, B.; Lamoureux, A.; Loustau, A.M.; Chilmonczyk, S.; Bremont, M. Fish rhabdovirus cell entry is mediated by fibronectin. J. Virol. 1999, 73, 7703-7709.
51. Roche, S.; Albertini, A.A.; Lepault, J.; Bressanelli, S.; Gaudin, Y. Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited. Cell Mol. Life Sci. 2008, 65, 1716-1728.
52. Florkiewicz, R.Z.; Rose, J.K. A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH. Science 1984, 225, 721-723.
53. Riedel, H.; Kondor-Koch, C.; Garoff, H. Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA. EMBO J. 1984, 3, 1477-1483.
54. Clague, M.J.; Schoch, C.; Zech, L.; Blumenthal, R. Gating kinetics of pH-activated membrane fusion of vesicular stomatitis virus with cells: Stopped-flow measurements by dequenching of octadecylrhodamine fluorescence. Biochemistry 1990, 29, 1303-1308.
55. Gaudin, Y.; de Kinkelin, P.; Benmansour, A. Mutations in the glycoprotein of viral haemorrhagic septicaemia virus that affect virulence for fish and the pH threshold for membrane fusion. J. Gen. Virol. 1999, 80, 1221-1229.
56. Roche, S.; Gaudin, Y. Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion. J. Virol. 2004, 78, 8746-8752.
57. Gaudin, Y. Reversibility in fusion protein conformational changes. The intriguing case of rhabdovirus-induced membrane fusion. Subcell. Biochem. 2000, 34, 379-408.
58. Gaudin, Y.; Ruigrok, R.W.; Knossow, M.; Flamand, A. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion. J. Virol. 1993, 67, 1365-1372.
59. Gaudin, Y.; Tuffereau, C.; Segretain, D.; Knossow, M.; Flamand, A. Reversible conformational changes and fusion activity of rabies virus glycoprotein. J. Virol. 1991, 65, 4853-4859.
60. Durrer, P.; Gaudin, Y.; Ruigrok, R.W.; Graf, R.; Brunner, J. Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses. J. Biol. Chem. 1995, 270, 17575-17581.
61. Roche, S.; Gaudin, Y. Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 2002, 297, 128-135.
62. Gaudin, Y.; Tuffereau, C.; Durrer, P.; Flamand, A.; Ruigrok, R.W. Biological function of the lowpH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusioninactive state-like conformation. J. Virol. 1995, 69, 5528-5534.
63. Albertini, A.; Bressanelli, S.; Lepault, J.; Gaudin, Y. Structure and working of viral fusion machinery. Curr. Top. Membr. 2011, 68, 49-80.
64. Carr, C.M.; Chaudhry, C.; Kim, P.S. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 14306-14313.
65. Kuzmin, P.I.; Zimmerberg, J.; Chizmadzhev, Y.A.; Cohen, F.S. A quantitative model for membrane fusion based on low-energy intermediates. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 7235-7240.
66. Lee, J.; Lentz, B.R. Secretory and viral fusion may share mechanistic events with fusion between curved lipid bilayers. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 9274-9279.
67. Herrmann, A.; Clague, M.J.; Puri, A.; Morris, S.J.; Blumenthal, R.; Grimaldi, S. Effect of erythrocyte transbilayer phospholipid distribution on fusion with vesicular stomatitis virus. Biochemistry 1990, 29, 4054-4058.
68. Yamada, S.; Ohnishi, S. Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes. Biochemistry 1986, 25, 3703-3708.
69. Roth, S.L.; Whittaker, G.R. Promotion of vesicular stomatitis virus fusion by the endosomespecific phospholipid bis(monoacylglycero)phosphate (BMP). FEBS Lett. 2011, 585, 865-869.
70. Chernomordik, L.V.; Frolov, V.A.; Leikina, E.; Bronk, P.; Zimmerberg, J. The pathway of membrane fusion catalyzed by influenza hemagglutinin: Restriction of lipids, hemifusion, and lipidic fusion pore formation. J. Cell Biol. 1998, 140, 1369-1382.
71. Zaitseva, E.; Mittal, A.; Griffin, D.E.; Chernomordik, L.V. Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. J. Cell Biol. 2005, 169, 167-177.
72. Roche, S.; Bressanelli, S.; Rey, F.A.; Gaudin, Y. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 2006, 313, 187-191.
73. Roche, S.; Rey, F.A.; Gaudin, Y.; Bressanelli, S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein g. Science 2007, 315, 843-848.
74. Heldwein, E.E.; Lou, H.; Bender, F.C.; Cohen, G.H.; Eisenberg, R.J.; Harrison, S.C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 2006, 313, 217-220.
75. Backovic, M.; Longnecker, R.; Jardetzky, T.S. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 2880-2885.
76. Kadlec, J.; Loureiro, S.; Abrescia, N.G.; Stuart, D.I.; Jones, I.M. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat. Struct. Mol. Biol. 2008, 15, 1024-1030.
77. Yin, H.S.; Wen, X.; Paterson, R.G.; Lamb, R.A.; Jardetzky, T.S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006, 439, 38-44.
78. Bullough, P.A.; Hughson, F.M.; Skehel, J.J.; Wiley, D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 1994, 371, 37-43.
79. Carneiro, F.A.; Stauffer, F.; Lima, C.S.; Juliano, M.A.; Juliano, L.; Da Poian, A.T. Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation. J. Biol. Chem. 2003, 278, 13789-13794.
80. Modis, Y.; Ogata, S.; Clements, D.; Harrison, S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427, 313-319.
81. Fredericksen, B.L.; Whitt, M.A. Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity. J. Virol. 1995, 69, 1435-1443.
82. Rocha, A.; Ruiz, S.; Tafalla, C.; Coll, J.M. Conformation- and fusion-defective mutations in the hypothetical phospholipid-binding and fusion peptides of viral hemorrhagic septicemia salmonid rhabdovirus protein G. J. Virol. 2004, 78, 9115-9122.
83. Stanifer, M.L.; Cureton, D.K.; Whelan, S.P. A recombinant vesicular stomatitis virus bearing a lethal mutation in the glycoprotein gene uncovers a second site suppressor that restores fusion. J. Virol. 2011, 85, 8105-8115.
84. Sun, X.; Belouzard, S.; Whittaker, G.R. Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein. J. Biol. Chem. 2008, 283, 6418-6427.
85. Wimley, W.C.; White, S.H. Partitioning of tryptophan side-chain analogs between water and cyclohexane. Biochemistry 1992, 31, 12813-12818.
86. Efrat, A.; Chernomordik, L.V.; Kozlov, M.M. Point-like protrusion as a prestalk intermediate in membrane fusion pathway. Biophys. J. 2007, 92, L61-63.
87. Kemble, G.W.; Danieli, T.; White, J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 1994, 76, 383-391.
88. Odell, D.; Wanas, E.; Yan, J.; Ghosh, H.P. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J. Virol. 1997, 71, 7996-8000.
89. Cleverley, D.Z.; Lenard, J. The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 3425-3430.
90. Jeetendra, E.; Ghosh, K.; Odell, D.; Li, J.; Ghosh, H.P.; Whitt, M.A. The membrane-proximal region of vesicular stomatitis virus glycoprotein G ectodomain is critical for fusion and virus infectivity. J. Virol. 2003, 77, 12807-12818.
91. Maillard, A.; Domanski, M.; Brunet, P.; Chaffotte, A.; Guittet, E.; Gaudin, Y. Spectroscopic characterization of two peptides derived from the stem of rabies virus glycoprotein. Virus Res. 2003, 93, 151-158.
92. Libersou, S.; Albertini, A.A.; Ouldali, M.; Maury, V.; Maheu, C.; Raux, H.; de Haas, F.; Roche, S.; Gaudin, Y.; Lepault, J. Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion. J. Cell Biol. 2010, 191, 199-210.
93. Gaudin, Y.; Raux, H.; Flamand, A.; Ruigrok, R.W. Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein. J. Virol. 1996, 70, 7371-7378.
94. Harrison, S.C. Viral membrane fusion. Nat. Struct. Mol. Biol. 2008, 15, 690-698.
95. Weissenhorn, W.; Hinz, A.; Gaudin, Y. Virus membrane fusion. FEBS Lett. 2007, 581, 2150-2155.
96. Mercer, J.; Schelhaas, M.; Helenius, A. Virus entry by endocytosis. Annu. Rev. Biochem. 2010, 79, 803-833.
97. Johannsdottir, H.K.; Mancini, R.; Kartenbeck, J.; Amato, L.; Helenius, A. Host cell factors and functions involved in vesicular stomatitis virus entry. J. Virol. 2009, 83, 440-453.
98. Superti, F.; Seganti, L.; Ruggeri, F.M.; Tinari, A.; Donelli, G.; Orsi, N. Entry pathway of vesicular stomatitis virus into different host cells. J. Gen. Virol. 1987, 68, 387-399.
99. Sun, X.; Yau, V.K.; Briggs, B.J.; Whittaker, G.R. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 2005, 338, 53-60.
100. Cureton, D.K.; Massol, R.H.; Saffarian, S.; Kirchhausen, T.L.; Whelan, S.P. Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog. 2009, 5, e1000394.
101. Cureton, D.K.; Massol, R.H.; Whelan, S.P.; Kirchhausen, T. The length of vesicular stomatitis virus particles dictates a need for actin assembly during clathrin-dependent endocytosis. PLoS Pathog. 2010, 6, e1001127.
102. Sieczkarski, S.B.; Whittaker, G.R. Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 2003, 4, 333-343.
103. Mire, C.E.; White, J.M.; Whitt, M.A. A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. PLoS Pathog. 2010, 6, e1000994.
104. Le Blanc, I.; Luyet, P.P.; Pons, V.; Ferguson, C.; Emans, N.; Petiot, A.; Mayran, N.; Demaurex, N.; Faure, J.; Sadoul, R.; et al. Endosome-to-cytosol transport of viral nucleocapsids. Nat. Cell Biol. 2005, 7, 653-664.
105. Raux, H.; Flamand, A.; Blondel, D. Interaction of the rabies virus P protein with the LC8 dynein light chain. J. Virol. 2000, 74, 10212-10216.
106. Jacob, Y.; Badrane, H.; Ceccaldi, P.E.; Tordo, N. Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein. J. Virol. 2000, 74, 10217-10222.
107. Poisson, N.; Real, E.; Gaudin, Y.; Vaney, M.C.; King, S.; Jacob, Y.; Tordo, N.; Blondel, D. Molecular basis for the interaction between rabies virus phosphoprotein P and the dynein light chain LC8: dissociation of dynein-binding properties and transcriptional functionality of P. J. Gen. Virol. 2001, 82, 2691-2696.
108. Mebatsion, T. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J. Virol. 2001, 75, 11496-11502.
109. Tan, G.S.; Preuss, M.A.; Williams, J.C.; Schnell, M.J. The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 7229-7234.
110. Mazarakis, N.D.; Azzouz, M.; Rohll, J.B.; Ellard, F.M.; Wilkes, F.J.; Olsen, A.L.; Carter, E.E.; Barber, R.D.; Baban, D.F.; Kingsman, S.M.; et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 2001, 10, 2109-2121.
111. Mentis, G.Z.; Gravell, M.; Hamilton, R.; Shneider, N.A.; O'Donovan, M.J.; Schubert, M. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins. J. Neurosci. Meth. 2006, 157, 208-217.
112. Klingen, Y.; Conzelmann, K.K.; Finke, S. Double-labeled rabies virus: Live tracking of enveloped virus transport. J. Virol. 2008, 82, 237-245.
113. Mire, C.E.; Dube, D.; Delos, S.E.; White, J.M.; Whitt, M.A. Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. J. Virol. 2009, 83, 12139-12150.
114. Kasermann, F.; Kempf, C. Low pH-induced pore formation by spike proteins of enveloped viruses. J. Gen. Virol. 1996, 77, 3025-3032.
115. Menager, P.; Roux, P.; Megret, F.; Bourgeois, J.P.; Le Sourd, A.M.; Danckaert, A.; Lafage, M.; Prehaud, C.; Lafon, M. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog. 2009, 5, e1000315.
116. Lahaye, X.; Vidy, A.; Pomier, C.; Obiang, L.; Harper, F.; Gaudin, Y.; Blondel, D. Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication. J. Virol. 2009, 83, 7948-7958.
117. Das, S.C.; Nayak, D.; Zhou, Y.; Pattnaik, A.K. Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. J. Virol. 2006, 80, 6368-6377.
118. Heinrich, B.S.; Cureton, D.K.; Rahmeh, A.A.; Whelan, S.P. Protein expression redirects vesicular stomatitis virus RNA synthesis to cytoplasmic inclusions. PLoS Pathog. 2010, 6, e1000958.
119. Panda, D.; Das, A.; Dinh, P.X.; Subramaniam, S.; Nayak, D.; Barrows, N.J.; Pearson, J.L.; Thompson, J.; Kelly, D.L.; Ladunga, I.; et al. RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 2011, doi:10.1073/pnas.1113643108.